| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) | 
|---|
| 10/13/2004 | CN1536077A High-yield recombinant influenza B virus strain and its application | 
| 10/13/2004 | CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound | 
| 10/13/2004 | CN1535726A Molecular adjuvant, its preparation and gene vaccine containing said molecular adjuvant | 
| 10/13/2004 | CN1535725A Viral myocarditis gene vaccine, its preparation method and application | 
| 10/13/2004 | CN1535724A New application of recombinant human interferon for preventing serious acute respiratory tract syndrome | 
| 10/13/2004 | CN1535722A Colostrum peptide and its application | 
| 10/13/2004 | CN1535709A Capsicum ethylsine tablet preparation and its preparation method | 
| 10/13/2004 | CN1535707A Isatis root extract composition, its preparation method and application | 
| 10/13/2004 | CN1535698A Chinese medicine compound preparation and its preparation process | 
| 10/13/2004 | CN1535696A Chinese medicine for resisting virus | 
| 10/13/2004 | CN1170934C Proteins derived from white spot syndrome virus and uses thereof | 
| 10/13/2004 | CN1170847C Giant-web bominator antimicrobial peptide and its prepn and gene | 
| 10/13/2004 | CN1170831C New process for preparation of vinyl-pyrrolidinone cephalosporine derivatives | 
| 10/13/2004 | CN1170830C Prepn. of levo-ofloxacin | 
| 10/13/2004 | CN1170829C Optically active pyrrolopyridazine compound | 
| 10/13/2004 | CN1170594C 弯曲菌疫苗 Campylobacter vaccine | 
| 10/13/2004 | CN1170584C Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives | 
| 10/13/2004 | CN1170564C Virus eliminating medicine | 
| 10/13/2004 | CN1170562C Medicine for treating tinea | 
| 10/13/2004 | CN1170549C Process for preparing 'Qianjin' capsule to treat genopathy | 
| 10/13/2004 | CN1170548C Pain relieving ointment and its preparation | 
| 10/13/2004 | CN1170543C Use of PEG-IFN-alpha and triazloe nucleoside for treatment of chronic hepatitis C | 
| 10/13/2004 | CN1170541C Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors | 
| 10/13/2004 | CN1170539C Antifungal oral composition containing itraconazole and process for preparing same | 
| 10/12/2004 | US6803449 Polypeptide for use in the diagnosis and treatment viral diseases | 
| 10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc | 
| 10/12/2004 | US6803363 Peritoneal dialysis solution with taurolidine | 
| 10/12/2004 | US6803361 Administering nucleotide sequence | 
| 10/12/2004 | US6803211 Cancer therapy | 
| 10/12/2004 | US6803057 Hydrogen peroxide disinfectant with increased activity | 
| 10/12/2004 | US6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses | 
| 10/12/2004 | US6803042 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides | 
| 10/12/2004 | US6803041 Chemically inactivated ehv-1 kya virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer. | 
| 10/12/2004 | US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil. | 
| 10/11/2004 | CA2423897A1 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases | 
| 10/10/2004 | CA2425086A1 Method of increasing the delayed-type hypersensitivity response by infusing lfa-1 specific antibodies | 
| 10/07/2004 | WO2004085682A2 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza | 
| 10/07/2004 | WO2004085650A1 A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (sars) | 
| 10/07/2004 | WO2004085633A1 A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | 
| 10/07/2004 | WO2004085479A2 Treatment of viral infections | 
| 10/07/2004 | WO2004085478A2 Improved fc fusion proteins | 
| 10/07/2004 | WO2004085437A1 Non-nucleoside reverse transcriptase inhibitors | 
| 10/07/2004 | WO2004085411A1 Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases | 
| 10/07/2004 | WO2004085406A1 Benzyl-pyridazinons as reverse transcriptase inhibitors | 
| 10/07/2004 | WO2004085399A1 Oxamide derivatives useful as raf-kinase inhibitors | 
| 10/07/2004 | WO2004084945A1 Eating controllers | 
| 10/07/2004 | WO2004084938A1 Improved vaccines | 
| 10/07/2004 | WO2004084937A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses | 
| 10/07/2004 | WO2004084935A2 Francisella strain for live vaccine | 
| 10/07/2004 | WO2004084926A1 Cell- and gland-restorative and/or anti-carcinogenic liquid agave extract and method of obtaining same | 
| 10/07/2004 | WO2004084922A1 Infection inhibitor for fishes and shellfishes | 
| 10/07/2004 | WO2004084916A1 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria | 
| 10/07/2004 | WO2004084915A1 Use of n-acetyl-d-aminoglycosamine in treatment of non-specific inflammations related to physical or chemical factors | 
| 10/07/2004 | WO2004084877A1 Composition for ophthalmic use | 
| 10/07/2004 | WO2004084856A2 Novel galenical system for active transport, method for preparation and use | 
| 10/07/2004 | WO2004084645A2 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent | 
| 10/07/2004 | WO2004069873A3 Antigen/antibody or ligand/receptor glycosylated specificity exchangers | 
| 10/07/2004 | WO2004062677A9 Bacteriophage for the treatment of bacterial biofilms | 
| 10/07/2004 | WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors | 
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use | 
| 10/07/2004 | WO2004007709A3 Production of polyketides | 
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists | 
| 10/07/2004 | WO2003105770A3 Carbocyclic nucleoside analogs as rna-antivirals | 
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof | 
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines | 
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway | 
| 10/07/2004 | WO2003018608A3 Process for purifying glycopeptide phosphonate derivatives | 
| 10/07/2004 | WO2002083059A3 Use of esters of long-chain fatty acids for treatment of autoimmune diseases | 
| 10/07/2004 | US20040198980 Selective rxr ligands | 
| 10/07/2004 | US20040198973 free from the two disadvantages of column chromatography and recovery of a difficulty soluble salt; reacting a diphenylphosphate carbapenem with a mercapto-compound of given formula; deprotecting and purifying the resulting compound by crystallization | 
| 10/07/2004 | US20040198838 Administering by mouth; side effect reduction; multilayer coating on tablet; fungicides | 
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects | 
| 10/07/2004 | US20040198801 Antiinflammatory agents; sepsis | 
| 10/07/2004 | US20040198790 Triazole compound containing a phosphonate group | 
| 10/07/2004 | US20040198756 Piperidien compound; bactericide | 
| 10/07/2004 | US20040198755 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials | 
| 10/07/2004 | US20040198739 Prevention reproduction of virus | 
| 10/07/2004 | US20040198736 Non-nucleoside reverse transcriptase inhibitors | 
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents | 
| 10/07/2004 | US20040198722 Pyrrolobenzodiazepines on solid supports; | 
| 10/07/2004 | US20040198715 prolonged serum half-life to permit treatment regimens of about once every 5-7 days or longer, while retaining antibacterial properties in vivo | 
| 10/07/2004 | US20040198689 Ribozyme sequences related to hiv resistance | 
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations | 
| 10/07/2004 | US20040198673 Composition for epigallocatechin gallate | 
| 10/07/2004 | US20040198662 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders | 
| 10/07/2004 | US20040198651 Secreted proteins | 
| 10/07/2004 | US20040198635 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway | 
| 10/07/2004 | US20040198633 Fungicide against Candida, Entomocorticum, Stereum, Phellinus, Peniophora, Xilaria, Rosellinia, Multiclavula, Hericium, and/or Tricholoma; flucytosine, miconazole,ketoconazole, fluconazole, amphotericin B extracted from culture of Streptomyces and/or nystatin | 
| 10/07/2004 | US20040197901 Ancillary composition for the preparation of committed mature dentritic cells | 
| 10/07/2004 | US20040197889 cell free hepatitis b virus transcription/translation in escherichia plasmid; enzyme inhibitors; mimetics; viricides; shelf life | 
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof | 
| 10/07/2004 | US20040197864 Derivatives of magainin and methods of production thereof | 
| 10/07/2004 | US20040197853 largely reduced of antigenicity compared to native trichosanthin (TCS), while retaining anti-tumor, anti-virus, abortifacient, and ribosome-inactivating protein activities; for treating leukemia | 
| 10/07/2004 | US20040197847 High throughput screening assays using fatty acid synthetic enzymes | 
| 10/07/2004 | US20040197426 Use of phyllanthus constituents for treating or preventing infections caused by hepatit | 
| 10/07/2004 | US20040197415 Stable pharmaceutical compositions of dalbavancin and methods of administration | 
| 10/07/2004 | US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen | 
| 10/07/2004 | US20040197399 N-fatty acid-amino acid conjugates and therapeutic uses | 
| 10/07/2004 | US20040197396 medicament for the treatment or prophylaxis of a herpes viral infection; high degree of robustness, highly regulated; administering the drug to mammals | 
| 10/07/2004 | US20040197351 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine |